Core Viewpoint - The article discusses the upcoming 2026 Spring Conference organized by Guotai Junan Securities, focusing on macroeconomic policies, asset allocation strategies, and industry-specific insights, particularly in technology and finance sectors [1][2]. Group 1: Macroeconomic Insights - The conference will feature discussions on global monetary policy changes and asset outlooks, highlighting the evolving international order and its impact on investment strategies [3][5]. - Key sessions will include a roundtable on ETF allocation strategies and macroeconomic forecasts for 2026, emphasizing the importance of adapting to new economic realities [3][4]. Group 2: Industry-Specific Strategies - The telecommunications sector will be a focal point, with sessions dedicated to fiber optic demand analysis and the future of satellite communication technologies [6][7]. - The conference will also explore advancements in AI and its implications for wealth management, showcasing new trends in resident wealth management and non-bank strategies [10][11]. Group 3: Investment Opportunities - The event will address investment opportunities in the beauty industry, using Proya as a case study to illustrate successful strategies in a competitive market [14]. - Discussions will include the exploration of new technologies in the medical field, such as RNAi platforms and brain-machine interfaces, indicating a growing interest in biotech investments [20][21]. Group 4: Global Geopolitical Context - The conference will analyze the current geopolitical landscape, including U.S.-China relations and their implications for global asset allocation [7][8]. - A roundtable will focus on the strategic reassessment of Chinese hard assets in light of international order reconstruction, emphasizing the need for adaptive investment strategies [7][8].

Group 1 - The article discusses the upcoming Guotai Haitong Spring Strategy Conference scheduled for March 25, 2026, in Shenzhen, focusing on innovative breakthroughs and global value opportunities [1] - Key topics include the exploration of long-term precise weight loss and metabolic benefits through a new generation RNAi technology platform, presented by Meng Na, Vice President of Capital Markets at Saint Gene Biotech [1] - Other presentations will cover applications and prospects of brain-machine interfaces and neuro-regulation medical technologies, as well as advancements in lipid management through small nucleic acid drugs, presented by industry experts [1]